219 related articles for article (PubMed ID: 33685999)
21. Modulation of TRPV4 by diverse mechanisms.
Darby WG; Grace MS; Baratchi S; McIntyre P
Int J Biochem Cell Biol; 2016 Sep; 78():217-228. PubMed ID: 27425399
[TBL] [Abstract][Full Text] [Related]
22. Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head.
Mah W; Sonkusare SK; Wang T; Azeddine B; Pupavac M; Carrot-Zhang J; Hong K; Majewski J; Harvey EJ; Russell L; Chalk C; Rosenblatt DS; Nelson MT; Séguin C
J Med Genet; 2016 Oct; 53(10):705-9. PubMed ID: 27330106
[TBL] [Abstract][Full Text] [Related]
23. Transient receptor potential vanilloid 4: The sixth sense of the musculoskeletal system?
Guilak F; Leddy HA; Liedtke W
Ann N Y Acad Sci; 2010 Mar; 1192():404-9. PubMed ID: 20392266
[TBL] [Abstract][Full Text] [Related]
24. Human skeletal dysplasia caused by a constitutive activated transient receptor potential vanilloid 4 (TRPV4) cation channel mutation.
Kang SS; Shin SH; Auh CK; Chun J
Exp Mol Med; 2012 Dec; 44(12):707-22. PubMed ID: 23143559
[TBL] [Abstract][Full Text] [Related]
25. Structural insights into the TRPV4-RhoA complex offer clues to solve the puzzle of TRPV4 channelopathies.
Hu X; Hu H
Cell Calcium; 2023 Dec; 116():102814. PubMed ID: 37839180
[No Abstract] [Full Text] [Related]
26. Natural history of TRPV4-Related disorders: From skeletal dysplasia to neuromuscular phenotype.
Ürel-Demir G; Şimşek-Kiper PÖ; Öncel İ; Utine GE; Haliloğlu G; Boduroğlu K
Eur J Paediatr Neurol; 2021 May; 32():46-55. PubMed ID: 33774370
[TBL] [Abstract][Full Text] [Related]
27. TRPV4 expresses in bone cell lineages and TRPV4-R616Q mutant causing Brachyolmia in human reveals "loss-of-interaction" with cholesterol.
Das R; Goswami C
Biochem Biophys Res Commun; 2019 Oct; 517(4):566-574. PubMed ID: 31387748
[TBL] [Abstract][Full Text] [Related]
28. Role of TRPV4 in skeletal function and its mutant-mediated skeletal disorders.
Das R; Goswami C
Curr Top Membr; 2022; 89():221-246. PubMed ID: 36210150
[TBL] [Abstract][Full Text] [Related]
29. Gain-of-function mutations of TRPV4 acting in endothelial cells drive blood-CNS barrier breakdown and motor neuron degeneration in mice.
Sullivan JM; Bagnell AM; Alevy J; Avila EM; Mihaljević L; Saavedra-Rivera PC; Kong L; Huh JS; McCray BA; Aisenberg WH; Zuberi AR; Bogdanik L; Lutz CM; Qiu Z; Quinlan KA; Searson PC; Sumner CJ
Sci Transl Med; 2024 May; 16(748):eadk1358. PubMed ID: 38776392
[TBL] [Abstract][Full Text] [Related]
30. Integrated proteomics, phosphoproteomics and metabolomics analyses reveal similarities among giant cell granulomas of the jaws with different genetic mutations.
Vitório JG; Duarte-Andrade FF; Pereira TDSF; Melo-Braga MN; Canuto GAB; Macedo AN; Lebron YAR; Moreira VR; Felicori LF; Lange LC; Santos LVS; Larsen MR; Gomes CC; Gomez RS
J Oral Pathol Med; 2022 Aug; 51(7):666-673. PubMed ID: 35706152
[TBL] [Abstract][Full Text] [Related]
31. A mutation in TRPV4 results in altered chondrocyte calcium signaling in severe metatropic dysplasia.
Hurd L; Kirwin SM; Boggs M; Mackenzie WG; Bober MB; Funanage VL; Duncan RL
Am J Med Genet A; 2015 Oct; 167A(10):2286-93. PubMed ID: 26249260
[TBL] [Abstract][Full Text] [Related]
32. Mice expressing mutant Trpv4 recapitulate the human TRPV4 disorders.
Weinstein MM; Tompson SW; Chen Y; Lee B; Cohn DH
J Bone Miner Res; 2014 Aug; 29(8):1815-1822. PubMed ID: 24644033
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia.
Krakow D; Vriens J; Camacho N; Luong P; Deixler H; Funari TL; Bacino CA; Irons MB; Holm IA; Sadler L; Okenfuss EB; Janssens A; Voets T; Rimoin DL; Lachman RS; Nilius B; Cohn DH
Am J Hum Genet; 2009 Mar; 84(3):307-15. PubMed ID: 19232556
[TBL] [Abstract][Full Text] [Related]
34. Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia.
Camacho N; Krakow D; Johnykutty S; Katzman PJ; Pepkowitz S; Vriens J; Nilius B; Boyce BF; Cohn DH
Am J Med Genet A; 2010 May; 152A(5):1169-77. PubMed ID: 20425821
[TBL] [Abstract][Full Text] [Related]
35. Accelerated osteoblastic differentiation in patient-derived dental pulp stem cells carrying a gain-of-function mutation of TRPV4 associated with metatropic dysplasia.
Han X; Kato H; Sato H; Hirofuji Y; Fukumoto S; Masuda K
Biochem Biophys Res Commun; 2020 Mar; 523(4):841-846. PubMed ID: 31954514
[TBL] [Abstract][Full Text] [Related]
36. The vanilloid transient receptor potential channel TRPV4: from structure to disease.
Everaerts W; Nilius B; Owsianik G
Prog Biophys Mol Biol; 2010 Sep; 103(1):2-17. PubMed ID: 19835908
[TBL] [Abstract][Full Text] [Related]
37. Mutations in calmodulin-binding domains of TRPV4/6 channels confer invasive properties to colon adenocarcinoma cells.
Arbabian A; Iftinca M; Altier C; Singh PP; Isambert H; Coscoy S
Channels (Austin); 2020 Dec; 14(1):101-109. PubMed ID: 32186440
[TBL] [Abstract][Full Text] [Related]
38. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family.
Dai J; Kim OH; Cho TJ; Schmidt-Rimpler M; Tonoki H; Takikawa K; Haga N; Miyoshi K; Kitoh H; Yoo WJ; Choi IH; Song HR; Jin DK; Kim HT; Kamasaki H; Bianchi P; Grigelioniene G; Nampoothiri S; Minagawa M; Miyagawa SI; Fukao T; Marcelis C; Jansweijer MC; Hennekam RC; Bedeschi F; Mustonen A; Jiang Q; Ohashi H; Furuichi T; Unger S; Zabel B; Lausch E; Superti-Furga A; Nishimura G; Ikegawa S
J Med Genet; 2010 Oct; 47(10):704-9. PubMed ID: 20577006
[TBL] [Abstract][Full Text] [Related]
39. Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms.
Deng Z; Paknejad N; Maksaev G; Sala-Rabanal M; Nichols CG; Hite RK; Yuan P
Nat Struct Mol Biol; 2018 Mar; 25(3):252-260. PubMed ID: 29483651
[TBL] [Abstract][Full Text] [Related]
40. TRPV4: Molecular Conductor of a Diverse Orchestra.
White JP; Cibelli M; Urban L; Nilius B; McGeown JG; Nagy I
Physiol Rev; 2016 Jul; 96(3):911-73. PubMed ID: 27252279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
